Related Experiment Video
Updated: Sep 13, 2025

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
Published on: April 19, 2013
Genetic variants linked to statin-associated Type 2 diabetes mellitus: Findings from the UK Biobank and the All of Us
Yoon-A Park1, Da Hoon Lee1, Jung Sun Kim2
1College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea.
Background And Purpose:
Statins are widely prescribed for the prevention of cardiovascular disease, yet recent studies suggest an increased risk of new-onset Type 2 diabetes mellitus. This study aimed to identify genetic variants associated with statin-associated new-onset Type 2 diabetes mellitus from the UK Biobank and All of Us.
Experimental Approach:
Among statin users, cases were defined as those diagnosed with Type 2 diabetes mellitus after statin initiation and controls as those never having diabetes mellitus. A genome-wide association study (GWAS) was performed using logistic regression analysis with an additive model using the UK Biobank. We conducted a replication analysis in the All of Us cohort using the lead variants identified in the UK Biobank. Additionally, we tested interaction analyses between statin use and lead variants.
Key Results:
The GWAS identified four significant lead variants. The most significant, TCF7L2 rs7903146, increased risk of new-onset Type 2 diabetes mellitus by 1.3-fold. Similarly, POU5F1 rs879882 was associated with a higher risk. By contrast, CCND2 rs76895963 and ADCY5 rs35841686 were associated with a lower risk. In the replication analysis of the All of Us cohort, TCF7L2 rs7903146, CCND2 rs76895963 and POU5F1 rs879882 remained significant. In the interaction analyses, those three lead variants also exhibited additive interactions with statin use.
Conclusion And Implications:
These findings provide insights that may support personalized statin therapy to mitigate diabetic risk.
More Related Videos
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
05:53Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Single Nucleotide Polymorphisms-SNPs
Diabetes Mellitus: Type 2 and Gestational
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Incomplete Dominance